Literature DB >> 16187223

NF-kappaB in the survival and plasticity of neurons.

Mark P Mattson1.   

Abstract

The transcription factor nuclear factor kappa-B (NF-kappaB) is involved in regulating responses of neurons to activation of several different signaling pathways in a variety of physiological and pathological settings. During development of the nervous system NF-kappaB is activated in growing neurons by neurotrophic factors and can induce the expression of genes involved in cell differentiation and survival. In the mature nervous system NF-kappaB is activated in synapses in response to excitatory synaptic transmission and may play a pivotal role in processes such as learning and memory. NF-kappaB is activated in neurons and glial cells in acute neurodegenerative conditions such as stroke and traumatic injury, as well as in chronic neurodegenerative conditions such as Alzheimer's disease. Activation of NF-kappaB in neurons can promote their survival by inducing the expression of genes encoding anti-apoptotic proteins such as Bcl-2 and the antioxidant enzyme Mn-superoxide dismutase. On the other hand, by inducing the production and release of inflammatory cytokines, reactive oxygen molecules and excitotoxins, activation of NF-kappaB in microglia and astrocytes may contribute to neuronal degeneration. Emerging findings suggest roles for NF-kappaB as a mediator of effects of behavioral and dietary factors on neuronal plasticity. NF-kappaB provides an attractive target for the development of novel therapeutic approaches for a range of neurological disorders.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16187223     DOI: 10.1007/s11064-005-6961-x

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  110 in total

Review 1.  NF-kappaB in neuronal plasticity and neurodegenerative disorders.

Authors:  M P Mattson; S Camandola
Journal:  J Clin Invest       Date:  2001-02       Impact factor: 14.808

2.  From calcium to NF-kappa B signaling pathways in neurons.

Authors:  Alain Lilienbaum; Alain Israël
Journal:  Mol Cell Biol       Date:  2003-04       Impact factor: 4.272

3.  Elevation of neuronal expression of NAIP reduces ischemic damage in the rat hippocampus.

Authors:  D G Xu; S J Crocker; J P Doucet; M St-Jean; K Tamai; A M Hakim; J E Ikeda; P Liston; C S Thompson; R G Korneluk; A MacKenzie; G S Robertson
Journal:  Nat Med       Date:  1997-09       Impact factor: 53.440

4.  Calbindin D28k blocks the proapoptotic actions of mutant presenilin 1: reduced oxidative stress and preserved mitochondrial function.

Authors:  Q Guo; S Christakos; N Robinson; M P Mattson
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-17       Impact factor: 11.205

5.  Lack of the p50 subunit of nuclear factor-kappaB increases the vulnerability of hippocampal neurons to excitotoxic injury.

Authors:  Z Yu; D Zhou; A J Bruce-Keller; M S Kindy; M P Mattson
Journal:  J Neurosci       Date:  1999-10-15       Impact factor: 6.167

6.  NF-kappaB p50-deficient mice show reduced anxiety-like behaviors in tests of exploratory drive and anxiety.

Authors:  Cheryl A Kassed; Miles Herkenham
Journal:  Behav Brain Res       Date:  2004-10-05       Impact factor: 3.332

7.  Nuclear factor-kappa B in rat brain: enhanced DNA-binding activity following convulsant-induced seizures.

Authors:  A V Prasad; W H Pilcher; S A Joseph
Journal:  Neurosci Lett       Date:  1994-03-28       Impact factor: 3.046

8.  Nerve growth factor-dependent activation of NF-kappaB contributes to survival of sympathetic neurons.

Authors:  S B Maggirwar; P D Sarmiere; S Dewhurst; R S Freeman
Journal:  J Neurosci       Date:  1998-12-15       Impact factor: 6.167

9.  Kainic acid-induced activation of nuclear factor-kappaB in rat hippocampus.

Authors:  Y Matsuoka; Y Kitamura; M Okazaki; K Terai; T Taniguchi
Journal:  Exp Brain Res       Date:  1999-01       Impact factor: 1.972

10.  Neuroprotective action of cycloheximide involves induction of bcl-2 and antioxidant pathways.

Authors:  K Furukawa; S Estus; W Fu; R J Mark; M P Mattson
Journal:  J Cell Biol       Date:  1997-03-10       Impact factor: 10.539

View more
  102 in total

Review 1.  Astrocytes, therapeutic targets for neuroprotection and neurorestoration in ischemic stroke.

Authors:  Zhongwu Liu; Michael Chopp
Journal:  Prog Neurobiol       Date:  2015-10-09       Impact factor: 11.685

2.  Carnosic Acid Induces Anti-Inflammatory Effects in Paraquat-Treated SH-SY5Y Cells Through a Mechanism Involving a Crosstalk Between the Nrf2/HO-1 Axis and NF-κB.

Authors:  Marcos Roberto de Oliveira; Izabel Cristina Custódio de Souza; Cristina Ribas Fürstenau
Journal:  Mol Neurobiol       Date:  2017-01-12       Impact factor: 5.590

3.  Immunohistochemical study on distribution of NF-kappaB and p53 in gerbil hippocampus after transient cerebral ischemia: effect of pitavastatin.

Authors:  Hiroko Tounai; Natsumi Hayakawa; Hiroyuki Kato; Tsutomu Araki
Journal:  Metab Brain Dis       Date:  2007-01-17       Impact factor: 3.584

4.  Chronic CXCL10 alters the level of activated ERK1/2 and transcriptional factors CREB and NF-kappaB in hippocampal neuronal cell culture.

Authors:  Hilda Bajova; Thomas E Nelson; Donna L Gruol
Journal:  J Neuroimmunol       Date:  2008-03-10       Impact factor: 3.478

Review 5.  Neuroinflammatory mechanisms in Parkinson's disease: potential environmental triggers, pathways, and targets for early therapeutic intervention.

Authors:  Malú G Tansey; Melissa K McCoy; Tamy C Frank-Cannon
Journal:  Exp Neurol       Date:  2007-07-17       Impact factor: 5.330

6.  Methamphetamine activates nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) and induces human immunodeficiency virus (HIV) transcription in human microglial cells.

Authors:  Emily S Wires; David Alvarez; Curtis Dobrowolski; Yun Wang; Marisela Morales; Jonathan Karn; Brandon K Harvey
Journal:  J Neurovirol       Date:  2012-05-22       Impact factor: 2.643

7.  Nuclear factor kappa B signaling regulates neuronal morphology and cocaine reward.

Authors:  Scott J Russo; Matthew B Wilkinson; Michelle S Mazei-Robison; David M Dietz; Ian Maze; Vaishnav Krishnan; William Renthal; Ami Graham; Shari G Birnbaum; Thomas A Green; Bruce Robison; Alan Lesselyong; Linda I Perrotti; Carlos A Bolaños; Arvind Kumar; Michael S Clark; John F Neumaier; Rachael L Neve; Asha L Bhakar; Philip A Barker; Eric J Nestler
Journal:  J Neurosci       Date:  2009-03-18       Impact factor: 6.167

Review 8.  A journey beyond apoptosis: new enigma of controlling metastasis by pro-apoptotic Par-4.

Authors:  Reyaz Ur Rasool; Debasis Nayak; Souneek Chakraborty; Archana Katoch; Mir Mohd Faheem; Hina Amin; Anindya Goswami
Journal:  Clin Exp Metastasis       Date:  2016-08-27       Impact factor: 5.150

9.  Intracellular mechanisms of N-acylethanolamine-mediated neuroprotection in a rat model of stroke.

Authors:  P Garg; R S Duncan; S Kaja; P Koulen
Journal:  Neuroscience       Date:  2009-12-03       Impact factor: 3.590

10.  TAp63 is a transcriptional target of NF-kappaB.

Authors:  Junfeng Wu; Johann Bergholz; Jinin Lu; Gail E Sonenshein; Zhi-Xiong Jim Xiao
Journal:  J Cell Biochem       Date:  2010-03-01       Impact factor: 4.429

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.